Skip to main content

Table 5 The characteristics and outcome of the fiberoptic bronchoscopies

From: Efficacy of premedication with intranasal dexmedetomidine for removal of inhaled foreign bodies in children by flexible fiberoptic bronchoscopy: a randomized, double-blind, placebo-controlled clinical trial

Variables

DEX Group

Control Group

P value

Size of LMA

2(2–2)

2(2–2)

0.574

Size of fiberoptic scope (mm)

4.0(4.0–4.0)

4(4.0–4.0)

0.637

Duration of anesthesia induction (min)

6(5–6.8)

7(5–10)

0.015

Duration of procedure (min)

13.5(10.3–20)

17(11–23.8)

0.738

Extubation time (min)

6.5(4.3–9.8)

6(4–9)

0.758

Recovery time (min)

16(8.3–28.8)

11(9–22)

0.445

Propofol

 No. (%)

3(15%)

12(60%)

0.003

 Dosage (mg)

30(15–35)

20(20–27.5)

0.734

Succinylcholine

 No. (%)

3(15)

4(20%)

0.677

 Dosage (mg)

10(10–10)

10(10–25)

0.629

Remifentanil

 No. (%)

1(5%)

8(40%)

0.008

 Dosage (ug)

10(10–10)

15(10–23.75)

0.667

  1. Data are expressed as median (interquartile range), number of patients (percentage)